The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients
Abstract
In a 20-year period, 223 patients (median age, 64.8 years) with myelofibrosis with myeloid metaplasia (MMM) had therapeutic splenectomy at our institution. Primary indications for surgery were transfusion-dependent anemia (45.3%), symptomatic splenomegaly (39.0%), portal hypertension (10.8%), and severe thrombocytopenia (4.9%). Operative mortality and morbidity rates were 9% and 31%, respectively. The 203 survivors of surgery had a median postsplenectomy survival time (PSS) of 27 months (range, 0-155). Among preoperative variables, thrombocytopenia (platelet count less than 100 × 109/L) and nonhypercellular bone marrow were identified as independent risk factors for decreased PSS. Durable remissions in constitutional symptoms, transfusion-dependent anemia, portal hypertension, and severe thrombocytopenia were achieved in 67%, 23%, 50%, and 0% of the patients, respectively. Histologic or cytogenetic features of bone marrow obtained before splenectomy did not predict a response in cytopenias. After splenectomy, substantial enlargement of the liver and marked thrombocytosis occurred in 16.1% and 22.0% of the patients, respectively. The thrombocytosis was associated with an increased risk of perioperative thrombosis and decreased PSS. The rate of blast transformation (BT) was 16.3%, and the risk of BT was higher in the presence of increased spleen mass and preoperative thrombocytopenia. However, the PSS of patients with BT was not significantly different from that of patients without BT. We conclude that presplenectomy thrombocytopenia in MMM may be a surrogate for advanced disease and is associated with an increased risk of BT and inferior PSS. However, the development of BT after splenectomy may not affect overall survival and does not undermine the palliative role of the procedure for the other indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dupriez, B., Morel, P., Demory, J., Lai, J., Simon, M., Plantier, I., & Bauters, F. (1996) · Blood · doi:10.1182/blood.v88.3.1013.1013 · Cited by 525
Visani, G., Finelli, C., Castelli, U., Petti, M. C., Ricci, P., Vianelli, N., Gianni, L., Zuffa, E., Aloe Spiriti, M. A., Latagliata, R., et al. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb02609.x · Cited by 190
Cervantes, F., Pereira, A., Esteve, J., Rafel, M., Cobo, F., Rozman, C., & Montserrat, E. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.782714.x · Cited by 174
Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea*
Löfvenberg, E., & Wåhlin, A. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb00212.x · Cited by 159
Martyré, M. C., Bousse‐Kerdilès, M. L., Romquin, N., Chevillard, S., Praloran, V., Demory, J. L., & Dupriez, B. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.292671.x · Cited by 135
Barosi, G., Ambrosetti, A., Centra, A., et al. (1998) · PubMed · Cited by 121
A prognostic classification of myelofibrosis with myeloid metaplasia
Barosi, G., Berzuini, C., Liberato, L. N., Costa, A., Polino, G., & D, E. A. M. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb02507.x · Cited by 111
A SYNDROME OF LOIN PAIN AND HAEMATURIA ASSOCIATED WITH DISEASE OF PARIPHERAL RENAL ARTERIES
Little, P. J., Sloper, J. S., & de Wardener, H. E. (1967) · QJM · doi:10.1093/oxfordjournals.qjmed.a067111 · Cited by 90
TGF-β and Megakaryocytes in the Pathogenesis of Myelofibrosis in Myeloproliferative Disorders
Martyré, M. C. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509054751 · Cited by 69
The ‘spent’phase of polycythaemia vera: hypersplenism in the absence of myelofibrosis
Najean, Y., Arrago, J. P., Rain, J., & Dresch, C. (1984) · British Journal of Haematology · doi:10.1111/j.1365-2141.1984.tb01283.x · Cited by 39
Cited by
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
Elliott, M. A., & Tefferi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05277.x · Cited by 473
Self-citationPolycythemia vera: myths, mechanisms, and management
Spivak, J. L. (2002) · Blood · doi:10.1182/blood-2001-12-0349 · Cited by 463
Kröger, N., Holler, E., Kobbe, G., Bornhäuser, M., Schwerdtfeger, R., Baurmann, H., Nagler, A., Bethge, W., Stelljes, M., Uharek, L., et al. (2009) · Blood · doi:10.1182/blood-2009-07-234880 · Cited by 396
Mesa, R. A., Li, C.-Y., Ketterling, R. P., Schroeder, G. S., Knudson, R. A., & Tefferi, A. (2005) · Blood · doi:10.1182/blood-2004-07-2864 · Cited by 389
Self-citationTefferi, A. (2006) · Blood · doi:10.1182/blood-2006-03-009746 · Cited by 313
Self-citation
Metadata
- Authors
- Tefferi, A., Mesa, R. A., Nagorney, D. M., Schroeder, G., & Silverstein, M. N.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-04-01
- Volume
- 95
- Issue
- 7
- Pages
- 2226-2233
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W135049235
- Cited by
- 285
- References
- 11
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. https://app.cochat.ai/papers/10.1182/blood.v95.7.2226
- The paper
- Tefferi, A., Mesa, R. A., Nagorney, D. M., Schroeder, G., & Silverstein, M. N. (2000). Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood. https://doi.org/10.1182/blood.v95.7.2226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.